Anteris Technologies Global AVR
NASDAQ AVR
$8.38 -0.15 (-1.77%)
As of: Sep 10, 2026 · 2:23 PM EDT

Anteris Technologies Global (AVR) Common Equity (2024 - 2026)

Anteris Technologies Global's (AVR) quarterly Common Equity came in at $251.7 million in Q2 2026, up 947.23% year-over-year from $24.0 million in Q2 2025, and down 9.6% quarter-over-quarter from $278.4 million in Q1 2026.

Analysis

Anteris Technologies Global (AVR) Common Equity (2024 - 2026) Analysis & Trends

Anteris Technologies Global (AVR) has reported Common Equity for 3 consecutive years, with $251.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Common Equity rose 947.23% year-over-year to $251.7 million in Q2 2026; TTM through Jun 2026 was $251.7 million, a 947.23% increase from a year earlier, with the FY2025 full-year figure at -$253000.0, down 100.4% from the prior year.
  • Common Equity was $251.7 million for Q2 2026 at Anteris Technologies Global, down from $278.4 million in the prior quarter.
  • Over five years, Common Equity peaked at $278.4 million in Q1 2026 and troughed at -$253000.0 in Q4 2025.
  • A 3-year average of $67.3 million and a median of $14.2 million in 2024 frame the typical range for Common Equity.
  • Across the five-year window, Common Equity tumbled 100.4% in 2025 and jumped 947.23% in 2026, its largest moves.
  • Over 3 years, Common Equity stood at $62.7 million in 2024, then slumped by 100.4% to -$253000.0 in 2025, then surged by 99574.31% to $251.7 million in 2026.
  • The last three Common Equity figures came in at $251.7 million (Q2 2026), $278.4 million (Q1 2026), and -$253000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 180.78 Bn 175.17 Bn 7.27 Bn 51.76 Bn
2 Intuitive Surgical 127.04 Bn 121.82 Bn 1.96 Bn 18.30 Bn
3 Medtronic 117.04 Bn 108.22 Bn 6.34 Bn 50.85 Bn
4 Stryker 103.86 Bn 100.38 Bn 4.50 Bn 23.99 Bn
5 Boston Scientific 63.50 Bn 62.96 Bn 3.85 Bn 25.17 Bn
6 Edwards Lifesciences 49.74 Bn 45.49 Bn 1.35 Bn 10.72 Bn
7 Alcon 32.99 Bn 31.53 Bn 1.68 Bn 21.60 Bn
8 Dexcom 32.12 Bn 30.17 Bn 830.00 Mn 2.62 Bn
9 Steris 20.69 Bn 20.21 Bn 684.20 Mn 7.22 Bn
10 Anteris Technologies Global 816.49 Mn 816.49 Mn 776,000.00 251.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 251.67 Mn
Mar 31, 2026 278.41 Mn
Dec 31, 2025 -253,000.00
Sep 30, 2025 3.70 Mn
Jun 30, 2025 24.03 Mn
Mar 31, 2025 43.11 Mn
Dec 31, 2024 62.68 Mn
Sep 30, 2024 2.90 Mn
Jun 30, 2024 2.55 Mn
Mar 31, 2024 4.40 Mn